Comment on "what happened to lithium?: antidepressant augmentation in clinical settings".
Terao
Takeshi
T
D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D017277:Drug Approval; D004359:Drug Therapy, Combination; D006801:Humans; D018020:Lithium Compounds / Q000627:therapeutic use*; D018579:Patient Selection; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration
D000927:Anticonvulsants; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds